on SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech Declares Share and Voting Rights Details
On September 3, 2026, Sartorius Stedim Biotech SA, headquartered in Aubagne, France, issued an official declaration regarding their share capital and voting rights. This disclosure complies with Article L 233-8-II of the French Code of Commerce and Article 223-6 of the AMF's general regulations.
As of August 31, 2026, the company's issued capital comprises 97,330,405 shares. The total number of theoretical voting rights, which includes treasury shares, amounts to 164,770,938. The net voting rights stand at 164,733,033, after accounting for treasury shares.
This announcement, disseminated via EQS Group, provides key insights into the corporate structure and shareholding pattern of Sartorius Stedim Biotech, reflecting transparency and adherence to regulatory requirements.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news